NDC Product Labeler Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. labeler's code is 13913. The labeler has 12 products that have an assigned National Drug Code.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Product Type | Status |
|---|---|---|---|---|---|---|
| 13913-008 | Zipsor | Diclofenac Potassium | Capsule, Liquid Filled | Oral | Human Prescription Drug | ACTIVE |
| 13913-012 | Cambia | Diclofenac Potassium | Powder, For Solution | Oral | Human Prescription Drug | ACTIVE |
| 13913-001 | Proquin XR | INACTIVATED | ||||
| 13913-002 | Glumetza | |||||
| 13913-003 | Glumetza | |||||
| 13913-004 | Gralise | |||||
| 13913-005 | Gralise | |||||
| 13913-006 | Gralise Starter Pack | |||||
| 13913-009 | Lazanda | |||||
| 13913-010 | Lazanda | |||||
| 13913-011 | Cambia | |||||
| 13913-013 | Lazanda |
